US Stock MarketDetailed Quotes
ABCL AbCellera Biologics
- 3.010
- +0.010+0.33%
Close Nov 29 13:00 ET
- 3.030
- +0.020+0.66%
Post 16:59 ET
889.05MMarket Cap-4934P/E (TTM)
3.050High2.950Low2.44MVolume3.010Open3.000Pre Close7.34MTurnover1.29%Turnover RatioLossP/E (Static)295.37MShares6.05552wk High0.82P/B569.48MFloat Cap2.33552wk Low--Dividend TTM189.20MShs Float71.910Historical High--Div YieldTTM3.33%Amplitude2.335Historical Low3.005Avg Price1Lot Size
About AbCellera Biologics Company
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Company Profile
SymbolABCL
Company NameAbCellera Biologics
Listing DateDec 11, 2020
Issue Price20.00
Founded2012
CEODr. Carl L.G. Hansen, PhD
MarketNASDAQ
Employees586
Fiscal Year Ends12-31
Address2215 Yukon Street
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV5Y 0A1
Phone1-604-559-9005
Websitehttp://www.abcellera.com
Company Executives
- Name
- Position
- Salary
- Dr. Carl L.G. Hansen, PhD
- Chairman of the Board, President and Chief Executive Officer
- 714.94K
- Andrew Booth
- Chief Financial Officer and Principal Accounting Officer
- 674.56K
- Dr. Veronique Lecault, PhD
- Director and Chief Operating Officer
- 650.59K
- Tryn Stimart
- Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
- 667.69K
- Dr. Andrew W. Lo
- Independent Director
- 55.00K
- Dr. Michael Hayden
- Lead Independent Director
- 105.00K
- John S. Montalbano, C.F.A.
- Independent Director
- 77.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data